Conditions: CPC · tirzepatide. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the specifics change the…
content-assay
Page 11 of 19 · 438 questions tagged content-assay.
Numbers first: JEEP · orforglipron. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to disagree,…
Numbers first: WWB · dulaglutide. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone else’s…
The particulars: QYB · semaglutide. An unexpected observation, and I would like a differential rather than reassurance. The conditions were within what I understood…
Concretely: oxidation · oral semaglutide · minus 80 °C. I want to know whether this is a real physical effect or an artefact of how it is measured. What prompted the…
What I have: JEEP · retatrutide. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone else’s…
The pharmacy is accredited and I have verified that on the accreditor register. The empirical answer seems settled. The explanation does not. If the honest answer is…
Conditions: Homopeptide · liraglutide. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the specifics…
Details up front: mazdutide · 2.5 mg/mL. This should be a straightforward calculation and I keep getting two different answers. The numbers are arbitrary; the method…
Numbers first: SWB · orforglipron. Before I write this off, I want to check whether it is a known failure mode. I have the lot number, the certificate and the date,…
Numbers first: SWB · orforglipron. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone else’s…
The specifics, since they change the answer: 96.8% · survodutide · WWB. I am at the decision point and I would rather think it through than improvise. I would rather…
Concretely: oxidation · oral semaglutide · 40 °C. I want to know whether this is a real physical effect or an artefact of how it is measured. What prompted the…
For reference: 99.1% · survodutide · JEEP. I would like to define my thresholds before I have a result, for obvious reasons. I want a plan with explicit stopping…
I have the report as a PDF with the chromatogram on page two, so I can quote specifics. This should be a straightforward calculation and I keep getting two different…
The case in front of me: aspartimide formation · tirzepatide · 40 °C. This is one of those things that everyone repeats and nobody derives. This matters practically,…
Stated plainly: aggregation · a GLP-1 receptor agonist · 25 °C. The empirical answer seems settled. The explanation does not. If the honest answer is that nobody…
For reference: QYB · ecnoglutide. Something has gone wrong and I would like to know how badly before I decide what to do. Nothing else in the setup changed, which is…
The lot number on the vial matches the certificate, which at least rules out the easy problem. I keep seeing this stated as a fact with no explanation attached, and…
The case in front of me: survodutide · 8 mg/mL. I want the working, not the result — I need to be able to redo it with different numbers. I care about the precision…
For reference: identity confirmation by mass spectrometry · survodutide. I am at the decision point and I would rather think it through than improvise. I would rather…
Setup, so nobody has to ask: a residual-solvent screen · a GLP-1 receptor agonist. I suspect the honest answer is that it depends, in which case I would like to know…
What I am working with: 98.4% · a GLP-1 receptor agonist · CPC. I would like to set this up properly once, rather than adjust it repeatedly. My budget is real but not…
Conditions: CPC · liraglutide. I have two candidate explanations and no way to distinguish them. The same procedure has worked without incident several times…